The Validity of the SQoL-18 in Patients with Bipolar and Depressive Disorders: A Psychometric Study from the PREMIUM Project.
bipolar and depressive disorders
bipolar disorders
depressive disorders
health services research
mental health
psychiatry
quality of life
schizophrenia
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
29 Jan 2022
29 Jan 2022
Historique:
received:
24
12
2021
revised:
27
01
2022
accepted:
28
01
2022
entrez:
15
2
2022
pubmed:
16
2
2022
medline:
16
2
2022
Statut:
epublish
Résumé
The S-QoL 18 is a self-administered questionnaire that assesses quality of life (QoL) among individuals with schizophrenia. This study aims to validate the S-QoL 18 in bipolar and depressive disorders for a more widespread use in psychiatric settings. This study was conducted in a non-selected sample of individuals with bipolar and depressive disorders in the day hospital of a regional psychiatric academic hospital. Two-hundred and seventy-two stable outpatients with bipolar (
Identifiants
pubmed: 35160196
pii: jcm11030743
doi: 10.3390/jcm11030743
pmc: PMC8836740
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Affect Disord. 2017 Mar 01;210:280-286
pubmed: 28068616
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Int J Med Educ. 2011 Jun 27;2:53-55
pubmed: 28029643
Psychol Bull. 1990 Mar;107(2):238-46
pubmed: 2320703
J Clin Med. 2022 Jan 16;11(2):
pubmed: 35054142
Br J Psychiatry. 2013 Jun;202:447-53
pubmed: 23661768
BMJ. 1997 Feb 22;314(7080):572
pubmed: 9055718
BMC Neurol. 2014 Apr 08;14:78
pubmed: 24708665
Schizophr Res. 2017 Apr;182:84-89
pubmed: 27789187
Br J Psychiatry. 1995 May;166(5):654-9
pubmed: 7620753
Neurosci Biobehav Rev. 2016 Oct;69:313-32
pubmed: 27395342
World J Psychiatry. 2016 Dec 22;6(4):399-409
pubmed: 28078204
Patient Prefer Adherence. 2020 Nov 03;14:2147-2161
pubmed: 33192054
Schizophr Res. 2010 Aug;121(1-3):241-50
pubmed: 20541912
Patient Prefer Adherence. 2019 Jan 21;13:165-177
pubmed: 30718945
J Affect Disord. 2016 Nov 01;204:131-7
pubmed: 27344622
Qual Life Res. 2018 Apr;27(4):1041-1054
pubmed: 28343349
Lancet Public Health. 2019 Nov;4(11):e583-e591
pubmed: 31677777
Psychiatry Res. 2007 Sep 30;153(1):33-8
pubmed: 17544154
Hum Psychopharmacol. 2010 Jan;25(1):1-16
pubmed: 20041478
Mult Scler Int. 2013;2013:524894
pubmed: 23533758
Int J Neuropsychopharmacol. 2019 Aug 1;22(8):467-477
pubmed: 31093646
Bipolar Disord. 2007 Feb-Mar;9(1-2):38-44
pubmed: 17391348
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
J Affect Disord. 1998 Jun;49(3):189-93
pubmed: 9629948
Med Care. 1993 Sep;31(9):834-45
pubmed: 8366685
J Affect Disord. 2021 Jan 1;278:33-45
pubmed: 32949871
PLoS One. 2013 Oct 25;8(10):e79677
pubmed: 24205390
Health Qual Life Outcomes. 2005 Nov 15;3:72
pubmed: 16288650
Can J Psychiatry. 2021 Mar;66(3):298-305
pubmed: 32783472
Expert Rev Pharmacoecon Outcomes Res. 2013 Jun;13(3):343-9
pubmed: 23763531
Acta Psychiatr Scand. 2015 Jan;131(1):51-60
pubmed: 24954156
J Affect Disord. 2007 Jan;97(1-3):155-60
pubmed: 16860875
Med Care. 1989 Mar;27(3 Suppl):S217-32
pubmed: 2646490
Int J Bipolar Disord. 2017 Dec;5(1):10
pubmed: 28188565
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
Int Clin Psychopharmacol. 2002 Nov;17(6):281-5
pubmed: 12409681
BMJ. 2017 Feb 20;356:j816
pubmed: 28219884
Lancet Reg Health Eur. 2021 Sep 07;10:100209
pubmed: 34806069
Schizophr Res. 2013 Jun;147(1):58-67
pubmed: 23566495
Neuropsychiatr Dis Treat. 2019 Jun 24;15:1649-1657
pubmed: 31296991
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Int J Epidemiol. 2014 Apr;43(2):476-93
pubmed: 24648481
Psychol Bull. 1959 Mar;56(2):81-105
pubmed: 13634291
J Mark Access Health Policy. 2021 Feb 23;9(1):1885789
pubmed: 33680364
Epidemiol Psychiatr Sci. 2015 Apr;24(2):121-40
pubmed: 25497332
Arch Psychiatr Nurs. 2003 Dec;17(6):270-5
pubmed: 14685951
Eur Psychiatry. 1997;12 Suppl 3:267s-74s
pubmed: 19698579